{"id":102745,"date":"2023-05-12T12:18:00","date_gmt":"2023-05-12T06:48:00","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=102745"},"modified":"2023-05-13T11:46:55","modified_gmt":"2023-05-13T06:16:55","slug":"large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/","title":{"rendered":"Large cap Pharma stock falls more than 7% in two days; Check here to know why"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3446134424\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of Dr. Reddy&#8217;s Laboratories Ltd opened at the price of \u20b94,543.30 on Friday, logging over a 7.60&nbsp; percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company&#8217;s recent announcement of Q4 FY 22-23 earnings.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2936356021\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The company posted positive Q4 FY23 results on Wednesday but missed shy of the street&#8217;s estimated profit of \u20b91,093.6 crore (As per Elara Securities Pvt Ltd).<\/p><p>As per Consolidated financials of the previous quarter, their operating revenues have declined from \u20b9 6,789&nbsp;crores in Q3 to \u20b9 6,315&nbsp;crores in Q4. Similarly, for&nbsp; YoY comparison, the revenues significantly increased from \u20b9 21,545 crores during FY 21-22 to \u20b9 24,669 crores in FY 22-23.<\/p><p>The net profit of the company has declined from&nbsp; \u20b9 1,237 crores in Q3 to&nbsp; \u20b9 952 crores in Q4, Similarly, for&nbsp; YoY comparison the net profit significantly increased from \u20b9&nbsp; 2,122 crores during FY 21-22 to \u20b9 4,470 crores in FY 22-23.<\/p><div class=\"trade-content_5\" id=\"trade-3816749579\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Dr. Reddy&#8217;s Laboratories Ltd is a leading India-based pharmaceutical company that offers a portfolio of products and services, including Active Pharmaceutical Ingredients, Custom Pharmaceutical services generics, biosimilars, and differentiated formulations, catering to both domestic and international clients.<\/p><p>The company declared a final dividend of \u20b940 (800% of the face value of Rs 5 ) per equity share for FY23.&nbsp;<\/p><p>Over the previous fiscal year, the company introduced new products and benefitted from favourable currency moves, resulting in a 27% year-on-year (YoY) growth in US business to \u20b9 2,532 crore, and an 11.6% YoY gain in European sales to 496 crores.<\/p><p>In India, the company released nine new items, which led to an increase in revenue growth&nbsp; of 32.5% year on year to&nbsp; \u20b9&nbsp; 1283.4 crores&nbsp; And the company reported a Net cash surplus of&nbsp; \u20b9&nbsp; 50.5 billion and a free cash flow of&nbsp; \u20b9 40.1 billion as of&nbsp; March FY23.<\/p><p>The basic profitability ratios exhibiting operational efficiencies such as return on equity (ROE) and return on capital employed (ROCE) showed an upward trend in the past couple of financial years. ROE moved from 11.35 percent during FY 21-22 to 19.35 percent in FY 22-23 and ROCE, keeping the time frame the same, took a shift from 15.44 percent to 25.95 percent and The debt-to-equity ratio stands at 0.06.<\/p><p>On a last year-to-date basis, the stock gained 6.22&nbsp; percent ranging from \u20b9 4,238.35 to the current price level. In the previous three years, the stock has gained around 19.28 percent ranging from \u20b9 3,735 to the current price level.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-1304631012\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>According to the latest data pertaining to the shareholding pattern, the promoters hold a&nbsp; 26.69&nbsp; percent stake, and Foreign Institutional Investors (FIIs) hold a 27.25 percent stake in the company for FY 22-23.<\/p><p><strong>Written by Omkar<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-3778932777\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of Dr. Reddy&#8217;s Laboratories Ltd opened at the price of \u20b94,543.30 on Friday, logging over a 7.60&nbsp; percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company&#8217;s recent announcement of Q4 FY 22-23 earnings.&nbsp; The [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31],"tags":[],"class_list":["post-102745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Large cap Pharma stock falls more than 7% in two days; Check here to know why - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of the company opened at the price of \u20b94,543.30 on Friday, logging over a 7.60\u00a0 percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company&#039;s recent announcement of Q4 FY 22-23 earnings.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Large cap Pharma stock falls more than 7% in two days; Check here to know why\" \/>\n<meta property=\"og:description\" content=\"The shares of the company opened at the price of \u20b94,543.30 on Friday, logging over a 7.60\u00a0 percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company&#039;s recent announcement of Q4 FY 22-23 earnings.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-12T06:48:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-13T06:16:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/\",\"url\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/\",\"name\":\"Large cap Pharma stock falls more than 7% in two days; Check here to know why - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-05-12T06:48:00+00:00\",\"dateModified\":\"2023-05-13T06:16:55+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of the company opened at the price of \u20b94,543.30 on Friday, logging over a 7.60\u00a0 percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company's recent announcement of Q4 FY 22-23 earnings.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Large cap Pharma stock falls more than 7% in two days; Check here to know why\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Large cap Pharma stock falls more than 7% in two days; Check here to know why - Trade Brains Features","description":"The shares of the company opened at the price of \u20b94,543.30 on Friday, logging over a 7.60\u00a0 percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company's recent announcement of Q4 FY 22-23 earnings.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/","og_locale":"en_US","og_type":"article","og_title":"Large cap Pharma stock falls more than 7% in two days; Check here to know why","og_description":"The shares of the company opened at the price of \u20b94,543.30 on Friday, logging over a 7.60\u00a0 percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company's recent announcement of Q4 FY 22-23 earnings.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-05-12T06:48:00+00:00","article_modified_time":"2023-05-13T06:16:55+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_image":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/","url":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/","name":"Large cap Pharma stock falls more than 7% in two days; Check here to know why - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-05-12T06:48:00+00:00","dateModified":"2023-05-13T06:16:55+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of the company opened at the price of \u20b94,543.30 on Friday, logging over a 7.60\u00a0 percent downfall from two trading sessions from a price of \u20b9 4,869 on Wednesday. One of the probable reasons for the low stock price movement is the company's recent announcement of Q4 FY 22-23 earnings.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/large-cap-pharma-stock-falls-more-than-7-in-two-days-check-here-to-know-why\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Large cap Pharma stock falls more than 7% in two days; Check here to know why"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/102745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=102745"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/102745\/revisions"}],"predecessor-version":[{"id":102750,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/102745\/revisions\/102750"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=102745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=102745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=102745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}